| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 139.271 | 182.810 | 197.332 | 182.951 | 258.411 | 179.061 | 205.081 | 211.815 | 73.705 | 12.619 |
| Total Income - EUR | 157.035 | 190.202 | 207.747 | 209.072 | 268.159 | 179.109 | 205.015 | 211.815 | 81.590 | 12.994 |
| Total Expenses - EUR | 77.282 | 61.103 | 93.455 | 135.442 | 157.682 | 113.718 | 124.192 | 112.421 | 44.152 | 12.335 |
| Gross Profit/Loss - EUR | 79.753 | 129.099 | 114.292 | 73.630 | 110.477 | 65.391 | 80.823 | 99.394 | 37.437 | 659 |
| Net Profit/Loss - EUR | 66.275 | 108.887 | 111.020 | 68.080 | 102.923 | 60.448 | 75.410 | 94.755 | 36.719 | 436 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dr.sandesc Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 81.514 | 69.963 | 105.237 | 11.007 | 11.816 | 10.022 | 7.706 | 5.637 | 343 | 7.528 |
| Current Assets | 280.393 | 195.496 | 139.473 | 90.363 | 139.685 | 203.297 | 269.420 | 319.673 | 364.067 | 351.940 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 96.543 | 2.718 | 15.115 | 54.032 | 77.234 | 92.943 | 86.391 | 81.021 | 78.865 | 70.185 |
| Cash | 183.851 | 192.777 | 124.358 | 36.331 | 62.451 | 110.354 | 183.029 | 238.652 | 285.201 | 281.755 |
| Shareholders Funds | 318.448 | 174.562 | 172.885 | 115.338 | 142.171 | 196.660 | 257.644 | 94.853 | 131.148 | 130.852 |
| Social Capital | 58 | 67 | 66 | 64 | 74 | 72 | 81 | 81 | 81 | 80 |
| Debts | 43.459 | 90.898 | 71.825 | 7.496 | 19.854 | 16.660 | 7.782 | 217.400 | 220.244 | 215.673 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Dr.sandesc Srl